Design and Characterization of Ciprofloxacin Loaded Niosomes for Enhanced Antibacterial Activity
International Journal of Drug Delivery Technology · 30.04.2026 · 16 (41s)
DOI: 10.25258/ijddt.16.41s.31 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 30.04.2026. Verfasst von Tapendra Kumar und 4 weiteren Autor:innen.
Abstract (Originalsprache)
The present study aimed to design, optimize, and evaluate ciprofloxacin-loaded niosomes for enhancedantibacterial activity and improved drug delivery performance. Ciprofloxacin-loaded niosomes were preparedusing the ether injection method with non-ionic surfactant (Tween 80) and cholesterol. Optimization wasperformed using Box–Behnken design (Design Expert® software), considering cholesterol concentration,surfactant concentration, and stirring speed as independent variables. The formulations were evaluated forparticle size, polydispersity index (PDI), zeta potential, drug content, entrapment efficiency, in vitro drugrelease, and morphology (SEM). Compatibility and crystallinity were assessed using FTIR and XRD.Antibacterial activity was evaluated against Staphylococcus aureus and Escherichia coli using the zone ofinhibition method. Stability studies were conducted as per ICH guidelines. The optimized formulation (CN4)exhibited a particle size of 134.6 nm, PDI of 0.127, and zeta potential of −32.5 mV, indicating good stabilityand uniformity. Drug content (95.62%) and entrapment efficiency (88.56%) were high, confirming effectivedrug incorporation. In vitro release studies showed sustained drug release up to 8 hours (~96.34%). SEManalysis revealed spherical, well-dispersed vesicles. FTIR confirmed drug–excipient compatibility, while XRDindicated amorphization of the drug within the niosomal matrix. Antibacterial studies demonstrated significantactivity with zones of inhibition (21.69 mm for S. aureus and 21.76 mm for E. coli), comparable to standardstreptomycin. Stability studies indicated minimal changes over 3 months. Ciprofloxacin-loaded niosomes weresuccessfully developed and optimized, showing enhanced stability, sustained release, and significantantibacterial activity. The study suggests that niosomal formulation is a promising strategy for improving thetherapeutic efficacy of ciprofloxacin.
Zitieren
APA
Kumar, T., Kumar, S., Sharma, S., Ahmad, R., & Kumar, V. (2026). Design and Characterization of Ciprofloxacin Loaded Niosomes for Enhanced Antibacterial Activity. International Journal of Drug Delivery Technology, 16(41s). https://doi.org/10.25258/ijddt.16.41s.31
Vancouver
Kumar T, Kumar S, Sharma S, Ahmad R, Kumar V. Design and Characterization of Ciprofloxacin Loaded Niosomes for Enhanced Antibacterial Activity. International Journal of Drug Delivery Technology. 2026;16(41s). doi:10.25258/ijddt.16.41s.31
BibTeX
@article{Kumar2026,
author = {Kumar, Tapendra and Kumar, Sandeep and Sharma, Saurabh and Ahmad, Rizwan and Kumar, Vishal},
title = {Design and Characterization of Ciprofloxacin Loaded Niosomes for Enhanced Antibacterial Activity},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {41s},
doi = {10.25258/ijddt.16.41s.31}
}
EUVIMED